PTPA and T-cell acute lymphoblastic leukemia: Further investigation into the phenothiazine mechanism of action found that treatment of T-cell acute lymphoblastic leukemia models resulted in PP2A-dependent degradation of MYC, a well-documented PP2A substrate (165).